# Xellia Pharmaceuticals USA LLC – FDA Inspection, Feb 7, 2022

Source: https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d429f017-a9d2-407b-a75e-05a5eb33faa5
Source feed: FDA_Inspections

> FDA inspection 1161837 of Xellia Pharmaceuticals USA LLC, February 07, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161837
- Company Name: Xellia Pharmaceuticals USA LLC
- Inspection Date: 2022-02-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1220071 - 2023-09-29](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8d9b38c-a723-4609-9dd4-0b9f92e5c364)
- FDA Inspection 1194565 - 2022-12-15
- FDA Inspection 1117006 - 2020-01-31
- [FDA Inspection 990058 - 2016-10-13](https://www.keypedia.com/records/fda_inspections/xellia-pharmaceuticals-usa-llc/d8709417-c6c0-4b50-9435-3d7c749a5d34)

Company: https://www.keypedia.com/companies/xellia-pharmaceuticals-usa-llc/a3a2eda2-040c-4cb8-8df0-2dd3fb12332f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
